American researchers have developed a new contraceptive pill capable of disrupting the ovulation process before sexual intercourse.
This is what will relieve women, currently in the majority to take on the issue of contraception. Researchers at Stanford University in California (USA) have developed a new birth control pill to swallow before sexual intercourse and no longer, as is the case today, on a daily basis. Their study, published in the BMJ Sexual and Reproductive Healthwas conducted on 9 women aged 18 to 35. Their menstrual cycles were observed during two months. Then they received a single dose of 30 mg of ulipristal acetate, an emergency contraceptive, and 30 mg of meloxicam, used in particular in the treatment of rheumatoid arthritis.
The birth control pill of the future?
Several blood samples were taken to measure their hormonal levels and pelvic ultrasounds were performed to observe whether ovulation had taken place or not. And good news: the condensate of these two molecules would have managed to “ disrupt ovulation at peak fertility “, report the researchers. Specifically, the ovulation process has been disrupted in six of the nine candidates in the study. The duration of their cycles would have been lengthened after taking this pill and would have increased from 29 to 32 days. Also their progesterone levels were lower. This birth control pill would be a promising candidate for evaluation as a pericoital oral contraceptive “, according to the researchers.
Other studies are still to be carried out, in particular for improve efficiency of this pill and measure the possible long-term side effects. Currently, the birth control pill has a large number of potential unwanted side effects, in addition to the stress associated with its daily intake. However, she remains the most widely used method of contraception, in front of the intrauterine device (IUD) and the condom. In case of doubt, the site QuestionSexuality lists in detail all the possibilities available via the portal ” Choosing birth control “.